Suppr超能文献

一种通过在脉络膜上腔注射曲安奈德治疗人工晶状体眼黄斑囊样水肿的自制针:病例报告

A manually made needle for treating Pseudophakic cystoid macular edema by injecting triamcinolone acetonide in the suprachoroidal space: A case report.

作者信息

Marashi Ameen, Zazo Aya

机构信息

Retina Specialist at Marashi Eye Clinic, Aleppo, Syria.

Aleppo Medical University, Aleppo, Syria.

出版信息

Am J Ophthalmol Case Rep. 2021 Dec 31;25:101254. doi: 10.1016/j.ajoc.2021.101254. eCollection 2022 Mar.

Abstract

PURPOSE

This case was conducted to report the effectiveness and security of a manually made needle to inject triamcinolone acetonide in the suprachoroidal space (SCS) in a 52-year-old female with pseudophakic cystoid macular edema (PCME) in the challenging socio-economical situations in Syria.

METHODS

This case report is an interventional case of a 52-year-old female presented with a four-week history of reduced vision secondary to Pseudophakic cystoid macular edema (PCME). The patient attended Marashi Eye Clinic Center for a clinical examination and followed up with Optical Coherence Tomography (OCT) at baseline. The patient was treated by one injection of triamcinolone acetonide and followed up within one week, 4 weeks, 8 weeks, 16 weeks, and 24 weeks in the suprachoroidal space (SCS) using a manually made needle with assessing the efficacy and potential ocular complications.

RESULTS

The best-corrected visual acuity (BCVA) had improved significantly from baseline 20/60 to 20/30 at 24 weeks with a complete anatomical resolution of macular edema at 24 weeks from baseline. No ocular complications were noticed during the study period.

CONCLUSIONS AND IMPORTANCE

Injecting triamcinolone acetonide in suprachoroidal space (SCS) using a manually made needle plays an essential role in treating Pseudophakic cystoid macular edema (PCME) without compromising security and efficiency.

摘要

目的

本病例旨在报告在叙利亚具有挑战性的社会经济状况下,使用自制针头在一名52岁人工晶状体眼黄斑囊样水肿(PCME)女性患者的脉络膜上腔(SCS)注射曲安奈德的有效性和安全性。

方法

本病例报告是一例52岁女性的介入性病例,该患者因人工晶状体眼黄斑囊样水肿(PCME)出现视力下降四周。患者前往马拉希眼科诊所中心进行临床检查,并在基线时接受光学相干断层扫描(OCT)检查。患者接受了一次曲安奈德注射治疗,并在一周、4周、8周、16周和24周时使用自制针头在脉络膜上腔(SCS)进行随访,评估疗效和潜在的眼部并发症。

结果

最佳矫正视力(BCVA)从基线时的20/60显著提高到24周时的20/30,黄斑水肿在24周时从基线开始完全解剖学消退。在研究期间未发现眼部并发症。

结论及重要性

使用自制针头在脉络膜上腔(SCS)注射曲安奈德在治疗人工晶状体眼黄斑囊样水肿(PCME)方面发挥着重要作用,且不影响安全性和有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fca4/8743223/b373ebd98c00/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验